Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$66.6K Hold
143
﹤0.01% 1030
2026
Q1
$54K Buy
+143
New +$61.2K ﹤0.01% 1045
2025
Q4
Sell
-146
Closed -$65.4K 822
2025
Q3
$65.4K Buy
+146
New +$66.1K ﹤0.01% 841
2025
Q2
Sell
-161
Closed -$99.1K 806
2025
Q1
$99.1K Buy
161
+56
+53% +$31.8K ﹤0.01% 751
2024
Q4
$55.6K Hold
105
﹤0.01% 853
2024
Q3
$63.1K Sell
105
-78
-43% -$44.2K ﹤0.01% 830
2024
Q2
$117K Buy
183
+69
+61% +$39.5K ﹤0.01% 766
2024
Q1
$66.7K Buy
+114
New +$69.3K ﹤0.01% 810

Other funds holding CHE

Mather Group's CHE Position: Q2 2026 in Review

Mather Group held its Chemed (CHE) position steady in Q2 2026 at 143 shares worth $66.6K. The position accounts for ﹤0.01% of the portfolio, ranked #1030.

Mather Group first reported a position in CHE in Q1 2024 and has held it in 8 quarters since. The position peaked at $117K in Q2 2024. 532 funds tracked by Wall St. Rank hold CHE as of Q2 2026.

  • Mather Group held 143 shares of Chemed worth $66.6K as of Q2 2026.
  • Mather Group left its Chemed share count unchanged in Q2 2026.
  • Chemed made up ﹤0.01% of Mather Group's portfolio in Q2 2026, its #1030 holding.
  • Mather Group first reported a position in Chemed in Q1 2024 and has held it in 8 quarters since.
  • Mather Group's Chemed position peaked at $117K in Q2 2024.
  • 532 funds tracked by Wall St. Rank held Chemed as of Q2 2026.

Based on Mather Group's 13F filing for Q2 2026, filed 27 Jul 2026.